바이노텍

We constantly develop and serve high-functional products
based on the proprietary nano drug delivery system and advanced
material development technology.

Binotec has succeeded in developing and mass-producing Dermathosome^™, a novel nano drug delivery system, through continuous research and development since its establishment in 2014. By overcoming the limitations of the existing liposome formulation, we have developed a proprietary nano drug delivery system that has enhanced penetration while ensuring high encapsulation efficiency and stability.
Dermathosome^™ is a platform drug delivery system that can encapsulate peptides, antioxidants, natural extracts, or any other substances. It has been applied to the REPOVE^® brand products and continuously upgraded by releasing the 2nd, 3rd, and 5th generation products.
We have mass-production facilities in Korea for the nano drug delivery system and have established all research infrastructure to develop and analyze it. Based on this, Binotec has succeeded in developing raw materials for food products following high functional cosmetics. We aim to be the world's number one biomaterial company through continuous technology development of high-functional materials for cosmetics, food, and pharmaceuticals.